Behov for større sikkerhed omkring medicin til børn og unge i Danmark

Anne-Cathrine Finnemann Viuff; Lene Bistrup; Pernille Mathiesen; Mia Ortved Bjerager; Tine Brink Henriksen

Behov for større sikkerhed omkring medicin til børn og unge i Danmark

Anne-Cathrine Finnemann Viuff, Lene Bistrup, Pernille Mathiesen, Mia Ortved Bjerager, Tine Brink Henriksen

Børne- og Ungeafdelingen

Publikation: Bidrag til tidsskrift › Review › Forskning › peer review

Abstract

Only 30% of medication used for children and adolescents and 10% of the medication used for neonates has been evaluated for use in these populations. Infants and children differ from adults regarding pharmacodynamic and -kinetics, but they also differ from each other due to e.g. age, weight, and body composition, as we argue in this review. There is only limited knowledge within this area leading to the use of off-label, extemporaneous and unlicensed medication. Greater national vigilance in medication for children and adolescent is warranted to secure better and safer medicine for newborns, infants, children and adolescents.

Bidragets oversatte titel	Greater vigilance in medication for children and adolescent is warranted in Denmark
Originalsprog	Dansk
Artikelnummer	V01200003
Antal sider	7
Tidsskrift	Ugeskrift for laeger
Vol/bind	182
Status	Udgivet - 2 nov. 2020

Adgang til dokumentet

https://ugeskriftet.dk/videnskab/behov-storre-sikkerhed-omkring-medicin-til-born-og-unge-i-danmark

Citationsformater

@article{8fbd8880e5d641818db9b3e811894e66,

title = "Behov for st{\o}rre sikkerhed omkring medicin til b{\o}rn og unge i Danmark",

abstract = "Only 30% of medication used for children and adolescents and 10% of the medication used for neonates has been evaluated for use in these populations. Infants and children differ from adults regarding pharmacodynamic and -kinetics, but they also differ from each other due to e.g. age, weight, and body composition, as we argue in this review. There is only limited knowledge within this area leading to the use of off-label, extemporaneous and unlicensed medication. Greater national vigilance in medication for children and adolescent is warranted to secure better and safer medicine for newborns, infants, children and adolescents.",

author = "Viuff, {Anne-Cathrine Finnemann} and Lene Bistrup and Pernille Mathiesen and Bjerager, {Mia Ortved} and Henriksen, {Tine Brink}",

year = "2020",

month = nov,

day = "2",

language = "Dansk",

volume = "182",

journal = "Ugeskrift for laeger",

issn = "0041-5782",

publisher = "Almindelige Danske Laegeforening",

}

TY - JOUR

T1 - Behov for større sikkerhed omkring medicin til børn og unge i Danmark

AU - Viuff, Anne-Cathrine Finnemann

AU - Bistrup, Lene

AU - Mathiesen, Pernille

AU - Bjerager, Mia Ortved

AU - Henriksen, Tine Brink

PY - 2020/11/2

Y1 - 2020/11/2

N2 - Only 30% of medication used for children and adolescents and 10% of the medication used for neonates has been evaluated for use in these populations. Infants and children differ from adults regarding pharmacodynamic and -kinetics, but they also differ from each other due to e.g. age, weight, and body composition, as we argue in this review. There is only limited knowledge within this area leading to the use of off-label, extemporaneous and unlicensed medication. Greater national vigilance in medication for children and adolescent is warranted to secure better and safer medicine for newborns, infants, children and adolescents.

AB - Only 30% of medication used for children and adolescents and 10% of the medication used for neonates has been evaluated for use in these populations. Infants and children differ from adults regarding pharmacodynamic and -kinetics, but they also differ from each other due to e.g. age, weight, and body composition, as we argue in this review. There is only limited knowledge within this area leading to the use of off-label, extemporaneous and unlicensed medication. Greater national vigilance in medication for children and adolescent is warranted to secure better and safer medicine for newborns, infants, children and adolescents.

M3 - Review

C2 - 33215585

SN - 0041-5782

VL - 182

JO - Ugeskrift for laeger

JF - Ugeskrift for laeger

M1 - V01200003

ER -

Behov for større sikkerhed omkring medicin til børn og unge i Danmark

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater